The second annual World Drug Safety Congress addresses the key challenges for drug safety professionals Worldwide. The World Drug Safety Congress addresses the crucial issues in the development and execution of drug safety programmes.
Exploratory Clinical Development USA will address the critical issues in achieving seamless first-in-man studies and will also provide advice on how to conduct effective clinical studies that allow you to make the right decision early on in clinical development.
Oncology Drug Development World Europe 2008 will address the critical strategic, scientific and regulatory issues in the development of targeted oncology therapeutics. This important meeting is for early to late stage development managers and directors working on oncology products.
Clinical Outsourcing World Americas addresses the major strategic and operational issues involved in outsourcing. The question now is not whether to outsource but which part of the development programme should be outsourced and how do you outsource efficiently?
Safety Pharmacology World Europe will bring together industry, regulators and academic bodies to discuss the scientific and regulatory challenges in QT analysis and reporting. Cardiovascular adverse effects continue to dominate the industry, so a well designed and executed QTc study is essential.
World Generic Medicines Congress Americas 2008 addresses the health economics, pricing and competition pressures facing the generics sector in US and building scale and value through globalization.
Health Technology Assessment World Eurpope will explore evidence based health care for pharmaceutical products, including value delivery for payers, patients and providers. In conjunction with the London School of Economics.
Clinical Outsourcing World Europe addresses the major strategic and operational issues involved in outsourcing. The question now is not whether to outsource but which part of the development programme should be outsourced and how do you outsource efficiently?
World Generic Medicines Congress Europe 2009 addresses the health economics, pricing and competition pressures facing the generics sector in Europe and building scale and value through globalisation.
The 3rd annual Exploratory Clinical Development Congress will address the critical issues in achieving seamless first in man studies and will provide advice on conducting effective studies that allow you to make the right decision early on in clinical development
